High-performance neurostimulator

The lntellis™ with AdaptiveStim™ rechargeable neurostimulator is powered by proprietary Overdrive™ battery technology. It is designed to overcome limitations with other SCS systems and is optimized for the increased energy demands of high energy waveforms.

  • Small and thin fully implantable spinal cord neurostimulator.
  • Designed for patient comfort and more flexible placement during the implant.
  • ~1 hour recharge — empty to full.
  • 95% battery capacity at 9 years, independent of therapy parameters or recharge preferences.
  • AdaptiveStim™ technology automatically adjusts the therapy as your patient moves, delivering a personalized treatment based on seven unique body positions.
  • Snapshot™ reporting, powered by AdaptiveStim™ technology, allows physicians to objectively monitor a patient's progress.
The Intellis product family for spinal cord stimulation

DTM™ SCS waveform

DTM™ SCS is a proprietary programming approach inspired by science and rooted in pre-clinical research, and adapted to provide superior clinical outcomes.

The DTM™ SCS 12-month RCT proved sustained superiority compared to conventional stimulation.

  • DTM™ SCS has an 84% back pain responder rate at 12-months.1
  • DTM™ SCS has a 69% profound back pain response rate (≥80% pain relief) at 12 months.1

Unimpeded 1.5T full-body MRI accessMR Safety Triangle

  • SureScan™ MRI technology allows MRI scans anywhere on the body, enabling diagnostic care.
  • Shielded leads and proprietary device safeguards help patients safely get an MRI.
  • Access matters — up to 98% of patients are expected to need at least one MRI within 10 years of implant.2

Creating new connections

The Medtronic adaptor extension creates a connection with certain Boston Scientific or Nevro leads. This enables patients with existing leads to gain access to superior DTM™ SCS therapy on Intellis™ INS.1 For patients wanting rapid recharge with Intellis™ INS or recharge-free convenience with Vanta™  INS, the adaptor extension allows you to offer meaningful pain relief with DTM™ SCS endurance waveform.3

Compatible products and features

Wireless External Neurostimulator

  • Wireless, sterile single-use external neurostimulator simplifies testing during trial and implant.
  • Designed for patient comfort and convenience.
Model Number 97725
Weight 71g (2.5oz)
Length 79mm (3.1in)
Width 74mm (2.9in)
Battery Type Non-rechargeable
Thickness 20mm (0.8in)
Front view of the Intellis wireless external neurostimulator

Clinician Programmer

  • Tablet with touchscreen interface
  • Secure, wireless programming outside the sterile field
  • Tailored programming workflows
  • Electronic transfer of a variety of reports
  • Bluetooth® communication
  • Requires the use of the Intellis™ clinician programmer app and communicator device
Clinician Programmer

Combined Patient Programmer and Recharger

  • Recharge from fully depleted battery.
  • Easy-to-adjust therapy.
  • Easy-to-read interface.
  • Large, pliable recharge antenna designed for patient comfort.
Combined Patient Programmer and Recharger

Compatible products

  • 1x8 Vectris™ and Vectris™ SureScan™ MRI percutaneous leads and Injex™ anchoring system models 97791 and 97792.
  • 16-electrode Specify™ SureScan™ MRI surgical leads.

Intellis™ with AdaptiveStim™ technology

Model 97715
Channels 2
Volume 13.9cc
Height 57.1mm (2.2in)
Width 47.2mm (1.9in)

Manuals and technical guides

Access prescriber, implant, MRI, and other manuals on the Medtronic Manual Library. Search by the product name (Intellis™) or model number (97715). You may also call 800-961-9055 for a copy of a manual.


© 2024 Medtronic. All rights reserved. Medtronic, Medtronic logo, and Engineering the extraordiary are trademarks of Medtronic. ®*Third-party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company.

Under excellent coupling condition when recharging is set to the highest speed.

MR Safety Triangle Under specific conditions. Refer to product labeling for full list of conditions. Patients with non-Medtronic leads and an EMBSNV20 adaptor extension are not eligible for an MRI.


Fishman M, Cordner H, Justiz R, et al.  12-Month Results from multicenter, open-label, randomized controlled clinical trial comparing differential target multiplexed spinal cord stimulation and traditional spinal cord stimulation in subjects with chronic intractable back pain and leg pain. Pain Pract. 2021; 00: 1–12. doi: 10.1111/papr.13066.


Desai MJ, Hargens LM, Breitenfeldt MD, et al. The rate of magnetic resonance imaging in patients with spinal cord stimulation. Spine. 2015;40(9):E531–537.


Peacock, Provenzano, Fishman, et al. Long-Term Clinical Outcomes of a Low-Energy Derivative Study of Differential Target Multiplexed™️ Spinal Cord Stimulation. Poster presented at: North American Neuromodulation Society (NANS) 26th Annual Meeting; Jan 12-15, 2023; Las Vegas, NV.

The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc. and any use of such marks by Medtronic is under license.